ValiÅ¡, M.; SobÃÅ¡ek, L.; VyÅ¡ata, O.; KlÃmová, B.; Andrýs, C.; Vokurková, D.; Masopust, J.; Pavelek, Z.
CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate. Cells 2019, 8, 456.
https://doi.org/10.3390/cells8050456
AMA Style
ValiÅ¡ M, SobÃÅ¡ek L, VyÅ¡ata O, KlÃmová B, Andrýs C, Vokurková D, Masopust J, Pavelek Z.
CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate. Cells. 2019; 8(5):456.
https://doi.org/10.3390/cells8050456
Chicago/Turabian Style
ValiÅ¡, Martin, Lukáš SobÃÅ¡ek, OldÅ™ich VyÅ¡ata, Blanka KlÃmová, Ctirad Andrýs, Doris Vokurková, Jiřà Masopust, and ZbyÅ¡ek Pavelek.
2019. "CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate" Cells 8, no. 5: 456.
https://doi.org/10.3390/cells8050456
APA Style
ValiÅ¡, M., SobÃÅ¡ek, L., VyÅ¡ata, O., KlÃmová, B., Andrýs, C., Vokurková, D., Masopust, J., & Pavelek, Z.
(2019). CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate. Cells, 8(5), 456.
https://doi.org/10.3390/cells8050456